Your best patient is about to cancel

At the European Congress on Obesity in mid-May, Lilly presented ATTAIN-MAINTAIN, the first Phase 3 trial built specifically around the maintenance phase. The results were published in Nature Medicine.

Patients who finished a course of injectable tirzepatide or semaglutide were switched to a daily oral pill or a placebo for 52 weeks.

The pill group held onto 78 to 82% of their weight loss. The placebo group held 38 to 50%, and some regained enough to be put on rescue treatment.

The clinical takeaway is now settled: stopping cold means regain. For retention teams, this is the proof point the maintenance conversation has been missing.

A meta-analysis from Anglia Ruskin University, covering more than 90,000 trial participants, found GLP-1 drugs significantly cut the risk of heart attack, stroke, heart failure, and early death over multiyear treatment.

This is bigger than a number on a scale. It moves GLP-1 from a cosmetic story to a cardiovascular one.

Most telehealth retention copy is still selling pounds lost. The clinical story your patients should be hearing is now about their heart, and almost nobody is using it.

The industry’s flagship conference ran May 12 to 14 in Orlando. The recurring message from the stage: telehealth’s future depends on regulation, reimbursement, and operations, not on new technology.

FAIR Health data shown at the event confirmed telehealth has settled into a steady post-pandemic baseline. The growth-by-novelty era is over.

When being telehealth stops being the growth story, what you do with a patient after acquisition becomes the whole game.

A patient hits their goal weight. That should be your strongest retention moment. For most telehealth brands it’s the cancellation nobody saw coming.

Pull up your longest lifecycle flow. The post-purchase or onboarding sequence that runs the deepest into the patient relationship.

For most weight-loss telehealth brands, it is only 1-2 months long. For the most robust ones, it ends somewhere around month 6. Right about when the patient hits their goal.

After that, the system goes quiet. The patient who just succeeded gets the general newsletter, or nothing.

That is the maintenance cliff. And the ATTAIN-MAINTAIN data just made it expensive to ignore.

The patient’s mental model is simple. Weight loss was a project, the project had an endpoint, and they hit it.

Cancelling is the rational next step. Nobody told them otherwise.

The reframe is now backed by a Phase 3 trial. Stop the drug cold, and roughly half the loss returns inside a year.

Maintenance is a clinical phase of treatment, not an optional extra. Your lifecycle has to say that out loud, at the milestone, in plain language.

If the only place a patient hears the word maintenance is a cancellation-flow afterthought, you have already lost most of them.

A patient at goal weight is your lowest-risk, highest-LTV cohort.

They are past the side-effect window. Past the plateau doubt. Proven to tolerate the treatment and proven to get results.

They are the cheapest patient you will ever keep. And they are the one your lifecycle system stops talking to.

The fix is a maintenance track: a milestone trigger, a content sequence for the step down to a lower dose, and identity-level content that answers who the patient is now that the weight is off.

None of that exists in a flow that ends at month 6.

Keeping a goal-weight patient on the full-dose, full-price plan invites a predictable cancellation: I don’t need this much anymore.

Letting them churn invites the regain the trial just measured.

The path between those two is a maintenance offer: a lower clinical dose, a right-sized price, a longer refill cycle.

In GLP-1 that often looks like a microdose or a custom maintenance kit. The patient reads it as “you earned the lighter version,” not as a push to spend more.

It costs margin per month. It converts a 6-month patient into a 2-year one. That math is not close.

Takeaway: Map your lifecycle past goal weight this week. If your longest flow ends at month 6, you are abandoning patients at the exact point they become your most profitable cohort. Build the maintenance milestone trigger first, the content track second, the plan tier third. The trigger alone stops the silent cancellation while you build the rest.

The 90,000-patient review this month put hard numbers on GLP-1 cardiovascular protection: lower heart attack, stroke, and mortality risk across years of treatment.

That is a stronger retention message than the scale, and it works on the patient who is bored of weighing in. “You are measurably lowering your risk of a heart attack” reaches someone that “you lost two more pounds” cannot.

Pull one campaign this quarter that reframes the treatment around what the bloodwork and the heart data show. The scale is a short story. The clinical record is the long one.

ATA NEXUS made it official from the main stage. Telehealth has normalized into a steady baseline, and the category tailwind that carried brands since 2020 is gone.

When the rising tide stops lifting every boat, the only growth lever you fully control is how much of each patient you keep.

Acquisition costs are set by an auction you do not run. Retention is the number on your P&L that responds directly to work you can do this month.

Pull every patient who has been on treatment for 6 or more months, or who has been stepped down to a maintenance dose.

For most telehealth brands, that group is sitting in no flow at all. They get the general newsletter or complete silence.

Build one trigger this week. Call it “maintenance reached.” Fire it on the goal-weight milestone or the dose-step-down event, whichever your data actually supports.

Behind it, send a single email for now: the reframe. “You hit your goal. Keeping it is the next phase, and it is a real one, not the finish line.”

You do not need the full maintenance track built to start. One trigger and one honest email stops the silent goal-weight cancellation while you build the rest.

If retention is your biggest revenue leak, that’s what we fix. growthtrigger.xyz

Reply to this with your biggest retention challenge. I read and respond to every single one.